<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>15 Haemolytic anaemias III: Acquired</title>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="../styles/main.css">
    <!-- Include MathJax -->
    <script>
    MathJax = {
        tex: {
            inlineMath: [['$', '$'], ['\\(', '\\)']],
            displayMath: [['$$', '$$'], ['\\[', '\\]']],
            processEscapes: true,
            processEnvironments: true,
            tags: 'ams' // Use AMS numbering of equations
        },
        svg: { fontCache: 'global' },
        options: {
            skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
        }
    };
    </script>
    <script src="https://polyfill.io/v3/polyfill.min.js?features=es6"></script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
    <div class="container">
        <article class="document-section" role="main">
            <!-- Top Navigation -->
            <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon"></span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="haematology-14-haemolytic-anaemias-II-inherited-membrane-and-enzyme-defects.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 37.5%;"></div>
                        </div>
                       <span class="progress-text">Lecture 15 of 40</span>
                    </div>
                    <a href="haematology-16-haemolytic-anaemias-IV-genetic-defects-of-haemoglobin.html" class="nav-button">
                        <span class="nav-text">Next Section</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>

            <header class="section-header">
                <h1 class="section-title">15 Haemolytic anaemias III: Acquired</h1>
                <div class="title-underline"></div>
            </header>

            <main class="section-content">
                
                <section id="autoimmune-haemolytic-anaemia" class="content-section" aria-labelledby="section-heading-1">
                    <h2 id="section-heading-1" class="section-heading">
                        <span class="heading-text">Autoimmune haemolytic anaemia</span>
                    </h2>
                    <div class="content-card">
                        <p>This is caused by autoantibodies against the red cell membrane. It is divided into warm and cold antibody types and each may be idiopathic or secondary to other diseases (see Table 13.1).</p>
                        
                        <h3 class="subsection-heading">Warm autoimmune haemolytic anaemia</h3>
                        <p>Antibody, typically IgG, has maximum activity at $37^{\circ}\mathrm{C}$.</p>
                        
                        <h4 class="subsubsection-heading">Clinical and laboratory features</h4>
                        <ul>
                            <li>Presents at any age, in either sex, with features of extravascular haemolytic anaemia of varying severity.</li>
                            <li>The spleen is often enlarged.</li>
                            <li>Blood film shows microspherocytes (Fig.15.1), polychromasia, anisocytosis, $\pm$ circulating nucleated red blood cells.</li>
                            <li>Direct antiglobulin test (DAT) is positive (Fig.15.2).</li>
                            <li>Antibody may be non-specific or directed against antigens in the Rh system.</li>
                            <li>IgG or IgG + complement (C3d) is detected on the red cell.</li>
                            <li>Free antibody may be present in the serum.</li>
                            <li>May be associated with immune thrombocytopenia (Evans' syndrome).</li>
                            <li>Antibody-coated red cells are destroyed in the reticuloendothelial system, especially the spleen.</li>
                        </ul>
                        
                        <h4 class="subsubsection-heading">Treatment</h4>
                        <ul>
                            <li>Corticosteroids, e.g. prednisolone 1 mg/kg orally with subsequent gradual reduction.</li>
                            <li>Blood transfusion if necessary.</li>
                            <li>Consider splenectomy if steroid therapy fails.</li>
                            <li>Other immunosuppressive drugs, e.g. azathioprine, cyclosporin, cyclophosphamide.</li>
                            <li>Remove cause, e.g. drug.</li>
                            <li>Treat underlying disease, e.g. chronic lymphocytic leukaemia (CLL), systemic lupus erythematosus.</li>
                        </ul>
                        
                        <figure>
                            <img src="../assets/images/2025_09_09_3fc5c60a4aba104b7634g-045-1.jpg" alt="Fig. 15.1 Peripheral blood film from a patient with warm autoimmune haemolytic anaemia, showing a nucleated red blood cell, polychromasia, and microspherocytes." class="content-image">
                            <figcaption>Fig. 15.1 Warm autoimmune haemolytic anaemia: peripheral blood film. There is a circulating nucleated red blood cell (NRBC), polychromasia and microspherocytes.</figcaption>
                        </figure>

                        <figure>
                            <img src="../assets/images/2025_09_09_3fc5c60a4aba104b7634g-045-2.jpg" alt="Fig. 15.2 Diagram illustrating the Direct Antiglobulin (Coombs') Test (DAT), where anti-human globulin is added to washed red blood cells, causing agglutination if they are coated with immunoglobulin or complement." class="content-image">
                            <figcaption>Fig. 15.2 Direct antiglobulin (Coombs') test (DAT) is a means of detecting immunoglobulin and/or complement coating the red blood cells. Red blood cells are washed and anti-human globulin is added. This may be of broad specificity or specific, e.g. for IgG, IgA, IgM or complement. If agglutination occurs, then the red blood cells must have been coated; if no agglutination occurs, the red blood cells were not coated. In the indirect antiglobulin test, red cells are first incubated with serum at $37^{\circ}\mathrm{C}$ for 30 min ; a DAT is then performed, which will be positive if there are antibodies in the serum reacting against the red blood cells.</figcaption>
                        </figure>

                        <h3 class="subsection-heading">Cold autoimmune haemolytic anaemia</h3>
                        <p>Antibody, typically IgM, has maximum activity at $4^{\circ}\mathrm{C}$.</p>
                        
                        <h4 class="subsubsection-heading">Clinical and laboratory features (Fig. 15.3)</h4>
                        <ul>
                            <li>Raynaud's phenomenon affecting the fingers, toes, nose and ears.</li>
                            <li>Positive DAT with C3d on red cells.</li>
                            <li>Cold agglutinins, usually IgM and directed against I or i antigen (especially in infectious mononucleosis) on red cells are present in serum, often to titres of 1:4000 or more. In primary form (cold haemagglutinin disease) the antibody is monoclonal and the patient may ultimately develop non-Hodgkin lymphoma.</li>
                            <li>Paroxysmal cold haemoglobinuria is a rare syndrome, precipitated by infections. Intravascular haemolysis is caused by the Donath-Landsteiner antibody which binds red cells in the cold but causes lysis at $37^{\circ}\mathrm{C}$.</li>
                        </ul>

                        <h4 class="subsubsection-heading">Treatment</h4>
                        <ul>
                            <li>Keep the patient warm.</li>
                            <li>Consider immunosuppression with chlorambucil or cyclophosphamide.</li>
                            <li>Consider plasma exchange to lower antibody titre.</li>
                        </ul>

                        <figure>
                            <img src="../assets/images/2025_09_09_3fc5c60a4aba104b7634g-046-1.jpg" alt="Fig. 15.3 Peripheral blood film showing red cell agglutinates, characteristic of cold agglutinins." class="content-image">
                            <figcaption>Fig. 15.3 Cold agglutinins: peripheral blood film. This patient developed anaemia 7 days after recovering from mycoplasma pneumonia; investigations revealed a cold autoantibody of anti-I specificity which was causing a low-grade haemolytic anaemia. Red cell agglutinates disappear if a blood film is prepared at $37^{\circ}\mathrm{C}$.</figcaption>
                        </figure>

                    </div>
                </section>

                <section id="alloimmune-haemolytic-anaemia" class="content-section" aria-labelledby="section-heading-2">
                    <h2 id="section-heading-2" class="section-heading">
                        <span class="heading-text">Alloimmune haemolytic anaemia</span>
                    </h2>
                    <div class="content-card">
                        <p>This is caused when antibody produced by one individual reacts against red cells of another. The three important situations are:</p>
                        <ol>
                            <li>mismatched blood transfusions (see Chapter 37);</li>
                            <li>haemolytic disease of the newborn (see Chapter 37); and</li>
                            <li>following marrow or solid organ transplantation.</li>
                        </ol>
                    </div>
                </section>

                <section id="drug-induced" class="content-section" aria-labelledby="section-heading-3">
                    <h2 id="section-heading-3" class="section-heading">
                        <span class="heading-text">Drug-induced immune haemolytic anaemia</span>
                    </h2>
                    <div class="content-card">
                        <p>Mechanisms include the following.</p>
                        <ul>
                            <li>Antibody directed against a drug (e.g. penicillin)-red cell membrane complex, the drug acting as a hapten.</li>
                            <li>Antibody against a drug (e.g. quinidine)-plasma protein complex with subsequent deposition of the immune complex on red cells.</li>
                            <li>Stimulation of autoantibody (warm type) production against the red cell, e.g. methyldopa, fludarabine.</li>
                        </ul>
                    </div>
                </section>

                <section id="fragmentation-syndromes" class="content-section" aria-labelledby="section-heading-4">
                    <h2 id="section-heading-4" class="section-heading">
                        <span class="heading-text">Red cell fragmentation syndromes</span>
                    </h2>
                    <div class="content-card">
                        <p>These occur when red cells are exposed to an abnormal surface (e.g. non-endothelialized artificial heart valve or arterial graft), or flow through small vessels containing fibrin strands (e.g. in disseminated intravascular coagulation) or damaged small vessels. This is termed microangiopathic haemolytic anaemia (MAHA) and occurs in thrombotic thrombocytopenic purpura, haemolytic uraemic syndrome, widespread adenocarcinoma, malignant hypertension, pre-eclampsia and meningococcal septicaemia. Haemolysis is both extra- and intravascular; blood film shows deeply staining fragmented red cells (see Fig. 29.5).</p>
                    </div>
                </section>
                
                <section id="infections" class="content-section" aria-labelledby="section-heading-5">
                    <h2 id="section-heading-5" class="section-heading">
                        <span class="heading-text">Infections</span>
                    </h2>
                    <div class="content-card">
                        <p>These may cause haemolysis by:</p>
                        <ul>
                            <li>direct damage to red cells (e.g. malaria);</li>
                            <li>toxin production (e.g. clostridium perfringens);</li>
                            <li>oxidant stress in G6PD-deficient individuals;</li>
                            <li>MAHA (e.g. meningococcal septicaemia);</li>
                            <li>autoantibody formation (e.g. infectious mononucleosis);</li>
                            <li>extravascular destruction (e.g. malaria).</li>
                        </ul>
                    </div>
                </section>

                <section id="chemical-physical-agents" class="content-section" aria-labelledby="section-heading-6">
                    <h2 id="section-heading-6" class="section-heading">
                        <span class="heading-text">Chemical and physical agents</span>
                    </h2>
                    <div class="content-card">
                        <p>Some drugs, e.g. dapsone, or chemicals, e.g. chlorate, cause haemolysis by oxidation even with normal G6PD levels. Severe burns and snake bites may also cause haemolysis.</p>
                    </div>
                </section>

                <section id="pnh" class="content-section" aria-labelledby="section-heading-7">
                    <h2 id="section-heading-7" class="section-heading">
                        <span class="heading-text">Paroxysmal nocturnal haemoglobinuria</span>
                    </h2>
                    <div class="content-card">
                        <p>This is a clonal disorder in which haemolysis is caused by a rare acquired mutation of the PIG-A gene in haemopoietic stem cells. This results in a defect of the phosphatidyl inositol anchor which tethers a large number of proteins to the cell membrane. The cells become abnormally sensitive to complement-mediated haemolysis (lack of MIRL, CD56 antigen). It is often associated with a hypoplastic marrow with neutropenia and thrombocytopenia. The clinical course is frequently complicated by recurrent venous thromboses, especially of large veins, e.g. hepatic or portal; also by iron deficiency and infections. Diagnosis is made by a positive acid lysis (Ham's) test and the presence of red cells lacking the CD56 antigen.</p>
                        
                        <h3 class="subsection-heading">Treatment</h3>
                        <ul>
                            <li>Iron is given for iron deficiency resulting from chronic intravascular haemolysis.</li>
                            <li>Transfusion of leucodepleted red cells may be necessary.</li>
                            <li>Warfarin may be needed life-long to prevent thrombosis.</li>
                            <li>Allogeneic stem cell transplant for very serious cases in young adults.</li>
                        </ul>
                    </div>
                </section>

            </main>

            <!-- Bottom Navigation -->
             <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon"></span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="haematology-14-haemolytic-anaemias-II-inherited-membrane-and-enzyme-defects.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 37.5%;"></div>
                        </div>
                       <span class="progress-text">Lecture 15 of 40</span>
                    </div>
                    <a href="haematology-16-haemolytic-anaemias-IV-genetic-defects-of-haemoglobin.html" class="nav-button">
                        <span class="nav-text">Next Section</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>

        </article>
    </div>
    <script src="../js/navigation.js"></script>
</body>
</html>